LAVA Medtech Acquisition priced its IPO of 10 million units at $10 each. Units begin trading on the Nasdaq today under LVACU.
Each consists of one share and one-half of a warrant. Once the units begin separate trading, the shares and warrants are expected to list under LVAC and LVACW.
The offering is expected to close Oct. 29.
The SPAC’s acquisition focus is on companies within the healthcare and healthcare-related industries, primarily in the United States and Canada.
RBC Capital Markets is sole book-running manager of the offering. The underwriters may purchase up to an additional 1.5 million units to cover over-allotments, if any. Read more.
